Adaptive Biotechnologies (ADPT) Tops Q1 EPS by 9c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $21.86 -4.62%
Revenue Growth %: +11.7%
Financial Fact:
Benefit from (provision for) income taxes: 2.06M
Today's EPS Names:
PEBK, DIT, AMC, More
Revenue Growth %: +11.7%
Financial Fact:
Benefit from (provision for) income taxes: 2.06M
Today's EPS Names:
PEBK, DIT, AMC, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q1 EPS of ($0.20), $0.09 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $52.44 million versus the consensus estimate of $42.81 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX sets date for maiden earnings report: Why August 4 is make-or-break
- Cardinal Health to acquire AdaptHealth diabetes unit and Strive Medical for $360M
- RBB Bancorp (RBB) Tops Q2 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
